Oversold

OSCR

Valuation57/ 100
Cash flow & growth84/ 100
Upside potential54/ 100
Risk potential53/ 100

OSCR's valuation appears fair, fundamentals are above averages and forward estimates point to earnings and revenue growth, though analyst coverage is limited and estimates vary widely.

Score change since last week

The score rose 2 points, mainly due to valuation and price changes. Price rose 5.8%, from $30.47 to $32.25.

Valuation and price changes added 2.1 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 23.4× versus the full-history median of 93.9× shown in the valuation table, producing 57.2/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 57.2/100. The model applies a 14.3% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 77.6× (18-month half-life). A reliable earnings-based price target is unavailable. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +42.8%, operating margin +5.3 percentage points. Free cash flow is 28.3% of revenue. The business score is 83.8/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Business trends and outlook support upside. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 61.3% upside, or about $52.86.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Historical price swings are the main risk driver, even without a sharp profit decline.

The stock’s historical price swings drive this figure; the separate operating stress is 24.9%. Price history and operating stress provide the reference because comparable earnings do not support a future PE target. Operating stress reflects revenue, earnings, margins, outlook and relevant debt exposure. The larger stress gives 53.2% downside, or about $15.34, with a 15% minimum.

This is a scenario based on our model, not a forecast or probability.

OSCR vs Historical averages

MetricCurrentAverageRelative
PE23x126x81% lower
PE percentile7.15186% lower
EPS$1.40-$2.08$3.48 higher
FCF$4.3B$451.9M859% higher
Loading historical comparisons…

OSCR’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

OSCR Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueStrong growth
Forward profitabilityStable
Analyst coverageLimited
Estimate dispersionWide

OSCR’s outlook is generally improving, though analyst coverage is limited.

OSCR PE Valuation

Loading pe valuation table…

This table applies OSCR's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

OSCR Earnings Per Share

Loading earnings per share…

This chart tracks OSCR's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

OSCR Quarterly Revenue

Loading quarterly revenue…

This chart tracks OSCR's quarterly revenue over time and shows how sales are changing from year to year.

OSCR Free Cash Flow

Loading free cash flow…

This chart tracks OSCR's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

OSCR Total Shares

Loading shares over time…

This chart tracks changes in OSCR's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

OSCR Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

OSCR PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares OSCR's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

OSCR Weekly Price

Loading weekly price…

This chart uses OSCR's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

OSCR Weekly Moving Averages

Loading weekly moving averages…

This chart compares OSCR's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

OSCR Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

PGEN

Same as last week
Valuation50/ 100
Cash flow & growth66/ 100
Upside potential51/ 100
Risk potential57/ 100

PGEN's valuation appears fair while fundamentals provide solid support and forward estimates point to a return to profit and improving margins, though analyst coverage is limited and estimates vary widely.

Valuation

Valuation stays neutral because earnings are difficult to compare across periods. Business trends, outlook and financial risk still contribute to the overall score.

Cash flow & growth

Business trends are strong. Over the past year: revenue +1875%, operating margin +2353.4 percentage points. Free cash flow is -135.1% of revenue. The business score is 65.8/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Business trends and outlook support upside. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 58.9% upside, or about $10.88.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Historical price swings are the main risk driver, even without a sharp profit decline.

The stock’s historical price swings drive this figure; the separate operating stress is 34%. Price history and operating stress provide the reference because comparable earnings do not support a future PE target. Operating stress reflects revenue, earnings, margins, outlook and relevant debt exposure. The larger stress gives 57.3% downside, or about $2.92, with a 15% minimum.

This is a scenario based on our model, not a forecast or probability.

PGEN vs Historical averages

MetricCurrentAverageRelative
PE8.4x14x42% lower
PE percentile5.95188% lower
EPS-$1.14-$0.66$0.49 lower
FCF-$115.8M-$74.3M-$41.5M
Loading historical comparisons…

PGEN’s earnings are below their historical averages, while its earnings multiple is lower.

PGEN Forward outlook

MetricOutlook
Forward valuation--
Forward earningsTurning positive
Forward revenueStrong growth
Forward profitabilityStrongly expanding
Analyst coverageLimited
Estimate dispersionWide

PGEN’s outlook is generally improving, supported by an expected return to profitability.

PGEN PE Valuation

Loading pe valuation table…

This table applies PGEN's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

PGEN Earnings Per Share

Loading earnings per share…

This chart tracks PGEN's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

PGEN Quarterly Revenue

Loading quarterly revenue…

This chart tracks PGEN's quarterly revenue over time and shows how sales are changing from year to year.

PGEN Free Cash Flow

Loading free cash flow…

This chart tracks PGEN's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

PGEN Total Shares

Loading shares over time…

This chart tracks changes in PGEN's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

PGEN Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

PGEN PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares PGEN's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

PGEN Weekly Price

Loading weekly price…

This chart uses PGEN's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

PGEN Weekly Moving Averages

Loading weekly moving averages…

This chart compares PGEN's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

PGEN Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.